KT&G, Launching New Medicine Development Business

보도자료 | 뉴스룸 | 미디어 | 13025

보도자료

2012. 03. 30

KT&G acquired Mazence, a biotech venture, last December and renamed it to KT&G Life Sciences with reinforced R&D capacities by hiring more experts on new medicine development.

관련 콘텐츠

Promoting ethical management through initiatives such as the designation of “KT&G Corporate Ethics Day” and the signing of the “Ethics Practice Pledge” by employees

KT&G Takes Part in the 22nd Yoon Kyung CEO Pledge Ceremony 2025

2025. 04. 25

President Bang is shown signing a comprehensive MOU on the same day with Billy Gifford, CEO of the t

KT&G Announces Additional Shareholder Return, Including Raising Dividend to ₩6,000 per Share; MOU wi

2025. 09. 23

Photo shows the ISO 45001 certificate awarded to KT&G’s Indonesian factory.

KT&G’s Indonesian Factory Acquires ‘ISO 45001’ Certification

2026. 01. 05